Detektion okkulter medullärer Schilddrüsenkarzinome bei Patienten eineruniversitären Schilddrüsen-Ambulanz: Diagnostischer Wert von Calcitonin-Screening, Pentagastrintest und Gastrinrezeptorszintigraphie

Ziel der vorliegenden Arbeit war es an einer großen Zahl von Patienten den Wert des Calcitonin Screenings zur Frühdiagnostik des medullären Schilddrüsenkarzinoms zu untersuchen. Insbesondere wurde untersucht, ab welchem Grenzwert des basalen Calcitoninwertes im Serum mit einem medullären Schildd...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Voigt, Kathrin
Beteiligte: Behr, Thomas M. (Prof. Dr. ) (BetreuerIn (Doktorarbeit))
Format: Dissertation
Sprache:Deutsch
Veröffentlicht: Philipps-Universität Marburg 2010
Radiologie
Schlagworte:
Online Zugang:PDF-Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

1. Juweid, M., Sharkey, R.M., Behr, T., Swayne, L.C., Herskovic, T., Pereira, M., Rubin, A.D., Hanley, D., Dunn, R., Siegel, J., Goldenberg, D.M. (1996): Radioimmunotherapy of Medullary thyroid cancer with Iodine-131-Labeled Anti- CEA Antibodies. J Nucl Med 37:905-911


2. Poppe, K., Verbruggen, L.A., Velkeniers, B., Finne, E., Body, J.J., Vanhaelst, L. (1999): Calcitonin reserve in different stages of atrophic autoimmune thyroiditis. Thyroid 9:1211-1214


3. Abnormal Pentagastrin response in a patient with Pseudohypoparathyreoidism. Experiment Clin Endocrinol Diab, Suppl 1:132


4. Stolarsky-Fredman, L., Leff, S.E., Klein, E.S., Crenshaw, E.B.III., Yeakley, J., Rosenfeld, M.G. (1990): A tissue-specific enhancer in the rat- calcitonin/CGRP gene is active in both neutral and endocrine cell types. Mol Endocrinol 4:497-504


5. Schröder, S., Kloppel, G. (1987): Carcinoembryonic antigen and non-specific cross-reacting antigen in thyroid cancer. An immunocytochemical study using polyclonal and monoclonal antibodies. Am J Surg Pathol 11:100-108


6. Kaserer, K., Scheuba, C., Neuhold, N. et al. (1998): C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin.


7. Nuclear Medicine imaging and treatment. In: Wartowsky, L., (Hrsg.): Thyroid Wolfe, H.J., Melvin, K.E.W., Cervi-Skinner, S.J., Al Saadi, A.A., Juliar, J.F., Jackson, C.E., Tahjian, A.H. (1973): C-cell hyperplasia preceding medullary thyroid carcinoma. New Engl J Med 289:437-441


8. Raue, F. (1997): Chemotherapie bei Schilddrüsenkarzinomen: Indikation und Ergebnisse. Onkologe 3:55-58


9. Kaltsas, G., Korbonits, M., Heintz, E., Mukherjee, J.J., Jenkins, P.J., Chew, S.L., Reznek, R., Monson, J.P., Besser, G.M., Foley, R., Britton, K.E., Grossmann, A.B. (2001): Comparison o f Somatostatin Analog and Meta- Iodobenzylguanidine radionuclides in the Diagnosis and Localization of Advanced neuroendocrine Tumors. J Clin Endocrinol Metab 86:895-902


10. Rendl, J., Reiners, C. (2002): Etablierte nuklearmedizinische Verfahren zur Lokalisationsdiagnostik des medullären Schilddrüsenkarzinoms. Medulläres Schilddrüsenkarzinom/hrsg. von Joachim Feldkamp et al.: de Gruyter S.19-32


11. Zeppa, P., Vetrani, A., Marino, M., Fulciniti, F., Boschi, R., De Rosa, G., Palombini, L. et al. (1990): Fine needle aspiration cytology of medullary thyroid carcinoma: A review of 18 cases. Cytopathol 1:35-44


12. Raue, F. et al. (1998): German medullary thyroid carcinoma / multiple endocrine neoplasia registry. German MTC Study Group. Langenbecks Arch.


13. Reiners, Chr. (1992): Imaging methods for medullary thyroid cancer. Recent Results Cancer Research 125:125-145


14. Juweid, M., Sharkey, R.M., Behr, T., Swayne, L.C., Rubin, A.D., Herskovic, T., Hanley, D., Markowitz, A., Dunn, R., Siegel, J., Kamal, T., Goldenberg, D.M. (1996): Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen. J Clin Oncol 14(4):1209-17


15. Scheuba, C., Kaserer, K., Weinhausl A. et al. (1999): Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests. Surgery 126:1089-1095


16. Kallinowski, F., Buhr, H.J., Meybie, H. et al. (1993): Medullary carcinoma of the thyroid: Therapeutic strategy derived from fifteen years of experience. Surgery 114:491


17. Kebebew, E., Ituart, Ph.,H.,G., Siperstein, A.E., Duh, Qu.-Y., Clark, O. et al. (2000): Medullary thyroid carcinoma: Clinical characteristics, treatment, prognostic factors, and comparison of staging systems. Cancer 88:1139-1148


18. Scheuba, C., Kaserer, K., Bieglmayer, C., Asari, R., Riss, P., Drosten, R., Niederle, B. (2008): Medullary thyroid microcarcinoma recommendations for treatment-a single-centre experience. Surgery 143(2):303


19. Raue, F., Frank-Raue, K., G rauer, A. et al. (1994): Multiple endocrine neoplasia type 2, clinical features and screening. Endocrinol Metab Clin of North America 23:137-156


20. Reeve, J.R., Eysselein, V.E., Ho, F.J. et al. (1994): Natural and synthetic CCK-58-Novel reagents for studying c holecystokinin physiology. In: Reeve, J.R.Jr., Eysselein, V., Solomon, T.E., Go, V.L.W., (Hrsg.): Cholecystokinin. New York: Ann New York Acad Science 713:11-21


21. Schröder, S., Holl, K., Padberg, B.C. (1992): Pathology of sporadic and hereditary medullary thyroid carcinoma. Recent Results Cancer Research 125:19-45


22. Shreve, P.D., Anzai, Y., Wahl, R.L. (1999): Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 19:61-77


23. Siggelkow, H. (2000): Presentation of a large kindred with familial medullary thyroid carcinoma (Cys611Phe) demonstrating low grade malignancy


24. Kaserer, K., Scheuba, C., Neihold, N., Weinhäusel, A., Vierhapper, H., Niederle, B. (2002): Recommendations for reporting C cell pathology of the thyroid. Wiener Klin. Wschr 114/7:274-278


25. (2000): Relative risk of cancer in sonographically detected thyroid nodules with calcifications. J Clin Ultrasound 28:347-352


26. Reubi, J.C., Chayvialle, J.A., Franc, B., Cohen, R., Calmettes, C., Modigliani,E. (1991): Somatostatin receptors and somatostatin content in medullary thyroid carcinomas. Lab Invest 64:567-573


27. Strauss, L.G., Conti, P.S. (1991): The application of PET in clinical oncology. J Nucl Med 32:623


28. Raue, F., Geiger, S., Buhr, H., Frank-Raue, K., Ziegler, R. (1993): The prognostic importance of calcitonin screening in familial medullary thyroid carcinoma. Dt. Med. Wschr 118(3):49-52


29. Schewerk, W.B., Grun, R., Wahl, R. (1985): Ultrasound diagnosis of C-cell carcinoma of the thyroid. Cancer 55:624